Simulations Plus Osake

Simulations Plus Rule of 40

40. säännön sääntö yhtiöstä Simulations Plus (SLP) 23.8.2026 päivämäärällä on −76,24 %. Edellisenä vuonna 40. säännön sääntö oli 26,27 % — muutos −390,16 % (matalampi).

Rule of 40

−76,24 %

YoY

−390,16%

Viimeksi päivitetty:

40. säännön sääntö yhtiöstä Simulations Plus on 2026 −76,24 % . 40. säännön sääntö yhtiöstä Simulations Plus oli 2025 26,27 % . Se laskee −390,16% matalampi edelliseen vuoteen verrattuna.

Simulations Plus Rule of 40 historia

  • 3 vuotta

  • 10 vuotta

  • 25 vuotta

  • Maksimi

Rule of 40
Date
Rule of 40
1.1.2018
57,62 USD
1.1.2019
45,85 USD
1.1.2020
50,33 USD
1.1.2021
35,94 USD
1.1.2022
43,67 USD
1.1.2023
25,17 USD
1.1.2024
26,27 USD
1.1.2025
−76,24 USD
Simulations Plus Rule of 40 historia
VUOSIRule of 40YoY
−76,24 %−390,16%
26,27 %+4,41%
25,17 %−42,38%
43,67 %+21,50%
35,94 %−28,59%
50,33 %+9,77%
45,85 %−20,42%
57,62 %+4,57%
55,10 %+21,73%
45,26 %−50,68%
91,78 %
Access this data via the Eulerpool API

Simulations Plus Osakeanalyysi

Mitä Simulations Plus tekee? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Simulations Plus osakkeesta

Yhtiön Simulations Plus 40. säännön sääntö on −76,24 % vuonna 2026.

Eurpoolissa voit löytää 40. säännön sääntö Simulations Plus:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

40. säännön sääntö sanoo, että yrityksen tulojen kasvuvauhti plus voittomarginaali olisi ylitettävä 40 %. Sitä käytetään laajalti SaaS- ja nopeasti kasvavien yritysten arvioimiseen.

Access this data via the Eulerpool API

Laatu — Simulations Plus

Kaikki tunnusluvut — Simulations Plus